Pharmatec delivery system patent
Executive Summary
Firm announced that the U.S. Patent Office has approved the second in a group of 10 patent applications covering Pharmatec's brain-specific drug delivery system. The 10 patent applications describe more than 200 drugs and over 40 categories of drugs combined with Pharmatec's carrier, firm said. Pharmatec has licensed the system to Smith Labs for use in combination with three generic drugs.